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the high-throughput detection of organelle composition and proteomic mapping of protein environment directly from primary tissue as well as the identification of interactors of insoluble proteins that form higher-order structures have remained challenges in biological research. We report a proximity-based labeling approach that uses an antibody to a target antigen to guide biotin deposition onto adjacent proteins in fixed cells and primary tissues, which allows proteins in close proximity to the target antigen to be captured and identified by mass spectrometry. We demonstrated the specificity and sensitivity of our method by examining the well-studied mitochondrial matrix. We then used the method to profile the dynamic interactome of lamin A/c in multiple cell and tissue types under various treatment conditions. the ability to detect proximal proteins and putative interactors in intact tissues, and to quantify changes caused by different conditions or in the presence of disease mutations, can provide a window into cell biology and disease pathogenesis.
Protein assemblies are critical to the function of all living cells. The protein interactome is dynamic-interactions may change with time, developmental stage, cell cycle progression, or tissue type. Characterizing protein interactions can provide important information about the locations and functions of a protein of interest. However, the effect of specific mutations on tissue-specific protein interactomes has rarely been studied in detail.
Distinct mutations within a single gene may result in a plethora of diseases. Over 400 different mutations of the lamin A/C (LMNA) gene give rise to more than 14 distinct phenotypes that affect a variety of tissues-among them lipodystrophies, muscular dystrophies and premature aging syndromes. The mechanistic links between these single-gene mutations and their highly variable phenotypes remain to be elucidated. Tissue-specific interactors may offer an explanation, but characterization of the tissue-specific lamin interactome has been challenging.
Analysis of the lamin interactome by standard coimmunoprecipitation (CoIP) is impractical, because the insoluble high-order structures created by the lamin filaments result in superfluous precipitation of unrelated proteins. Several attempts to identify lamin interactors and to characterize the protein composition of the nuclear envelope (NE) have been made with various genetic and biochemical approaches (abbreviated BioID 1 , OneSTrEP-tag 2 , Y2H 3 , Lamin A/C tail 4 , Liver LB BioID 5 and FACS + salt 6 ). While multiple known and novel interactors were identified by these methods, their applications were limited to single cell lines and showed only a modest overlap amongst different data sets (see below).
Previously published proximity-based labeling methods also have generally required the prior insertion of a fusion gene in cell lines or in the germline, and thus they cannot be used on primary human tissue samples. To overcome these limitations, we have developed an antibody-guided, proximity-based labeling method denoted biotinylation by antibody recognition (BAR). We validated our method on a mitochondrial matrix protein and applied it to identify the interactors of lamin A/C in immortalized cell lines, primary cell culture, and primary human muscle and adipose tissues. We further expanded the method to perform differential proteomics analysis and identified stress-and mutation-induced changes to the composition of the NE.
results

Biotinylation by antibody-recognition method
The BAR method is designed to identify proteins in the vicinity of an antigen (Fig. 1a) . In a fixed and permeabilized tissue sample, a primary antibody is used to target a protein of interest. In the presence of hydrogen peroxide and phenol biotin, a secondary HRP-conjugated antibody creates free radicals, which results in biotinylation of proteins in close proximity to the target protein. As biotin is covalently attached, harsh conditions may then be used for reverse cross-linking and protein solubilization. Streptavidin-coated beads are used to precipitate the biotinylated proteins, which are then detected by tandem mass spectrometry. When possible, stable isotope labeling by amino acids in cell culture (SILAC) can be used to contrast signal coming from the target of interest with signal arising outside the region of interest. estimation of specificity and sensitivity by mitochondrial proximity labeling We benchmarked the performance of our method on the mitochondrion, an organelle whose protein composition has been extensively characterized by multiple methods [7] [8] [9] [10] [11] [12] . We targeted ATP synthase subunit alpha (ATP5A) and used the nonmitochondrial protein Ku80 as background. Of the 219 proteins that have a heavy-to-light SILAC ratio above 2, ~95% were known mitochondrial proteins (Fig. 1b and Supplementary Data) . Of these 219 proteins, ~74% were known mitochondrial matrix proteins. Of all mitochondrial matrix proteins passing quantification criteria, 88% were included in the list of 291 proteins. Of note, we do not expect all known matrix proteins to be enriched in our sample, as for some of them, like GRHPR, most of the protein localizes outside the mitochondria. Of the 219 identified proteins, only ~1.4% (3/219) were known nonmitochondrial proteins (i.e., potential false positives).
lamin A/c proximity labeling in hela cells
We applied BAR to identify proteins in the vicinity of lamin A/C in HeLa cells. Biotin was successfully deposited at the NE, as evident from super-resolution microscopy (Fig. 1c) . Biotinylated proteins were pulled down with streptavidin-coated beads and analyzed by western blot and mass spectrometry of in-gel-digested proteins ( Supplementary Fig. 1a-c) . In addition to identifying the targeted lamin A/C, we identified multiple known interactors of lamin A/C, including lamin B1, lamin B2 and laminaassociated polypeptide 2 (LAP2) (Supplementary Fig. 1d and Supplementary Data).
ratiometric analysis
To improve on these results, we sought to increase signal intensity. Reaction time determines the labeling radius and signal intensity. While limiting the labeling radius reduced the number of non-NE proteins identified, it also decreased the signal intensity both for rare and abundant NE proteins (Supplementary Fig. 2a) . By contrast, increasing the reaction time resulted in signal arising from leakage to non-NE proteins. To overcome this, we employed ratiometric labeling 11 .
We employed two strategies. (i) As the majority of signal leakage, as well as signal originating from nucleoplasmic lamin, labels the nucleoplasm, we contrasted signal originating from the nuclear envelope with a signal of active chromatin (H3K27ac) using SILAC.
(ii) An adjacent control can occasionally be found for some subcellular locations 11 ; however, this may not be the case for proteins with multiple subcellular locations or proteins found between distinct cellular structures. Thus, we also determined enrichment by comparing the streptavidin-bound fraction with the unbound fraction. When contrasting with active chromatin (H3K27ac), known NE interactors showed the highest SILAC ratios, with all three lamin proteins ranked in the top 6 (out of ~1,300 proteins passing ≥3 peptide-quantification criteria). Alternatively, comparing to the unbound fraction identified more (Fig. 1d) nuclear pore complex proteins, possibly because of inner-nuclear roles of some of these proteins. Compared to our 'in-gel' data set, ratiometric labeling resulted in a modest improvement in data set quality and a significant improvement in protein signal and peptide count, thus enabling better quantification (Supplementary Data).
comparison with six published lamin interactomes We compared our BAR results to those obtained from six other methods [1] [2] [3] [4] [5] [6] . The overlap between the six previously published data sets, while statistically significant, is small (Supplementary Data and Supplementary Fig. 2b ). To gain a better estimate of coverage of true-positive results, we defined high-confidence interactors as proteins identified by three or more data sets. 81% (71/88) of these proteins were identified by our LMNA-H3K27ac data set (Fig. 1e) . Similar conclusions resulted from comparing the Gene Ontology enrichments of the various data sets (Fig. 1f) .
labeling with different antibodies and other nuclear envelope proteins
To assess the effect of antibody quality and binding site on the data generated, we performed SILAC experiments, labeling heavy and light cells with different lamin A/C antibodies. After normalization, the ratio for the majority of NE proteins, and in particular proteins where quantification results were robust, did not significantly deviate from 1 ( Supplementary Fig. 2c and Supplementary Data).
The reaction-labeling radius does not enable the discrimination of proteomes of adjacent proteins. This can be an advantage when, for example, studying how null mutations affect organelle composition by targeting an adjacent unchanged protein. B-type lamin filaments are in close proximity to lamin A/C near the NE but are not found in the nucleoplasm. Indeed, only modest differences in protein abundance were observed (Supplementary and Supplementary Data). Overall, these results suggest that antibody localization, and not protein identity or binding epitope, is the primary determinant of the protein identified.
lamin A/c proximity labeling in primary human tissue
An underlying assumption of cell culture usage is that it mimics relevant processes that occur throughout the entire organism. While this assumption is often valid, in many cases it is not. To overcome such limitations, we attempted to identify lamin A/C interactors in primary human tissue relevant to laminopathies. We successfully labeled the NE in postmortem tissue samples. NE morphology in these samples deviated considerably from the classical view of a smooth round sphere around the nucleus. For example, muscle myofibrils created grooves in the nucleus, which correlate not only with the distribution of lamin A/C, but also of DNA ( Fig. 2a and Supplementary Fig. 3a) . Some nuclei in adipose samples had a doughnut shape ( Fig. 2b and Supplementary Fig. 3b ), a phenotype that was previously reported in cell culture but not in primary human tissues 13 . While different tissues had multiple lamin A/C interactors in common, some proteins were either found exclusively or with greater abundance in a particular tissue. For example, muscular LMNA-interacting protein (MLIP) was found in all muscle samples but not in HeLa or adipose samples (Supplementary Data). Proteins identified by two or more unique peptides in one experiment had an ~90% chance of being detected (at any level) in a replicate experiment (Fig. 2c) . However, signal correlation between replications, while highly statistically significant, was insufficient to quantify small differences without multiple repetitions ( Fig. 2d) (P < 10 −50 ). Overall, skeletal muscle tissue showed higher similarity to smooth muscle tissue than to adipose tissue (Fig. 2e) . These results provide further evidence that NE composition varies between tissues 14 . Muscle tissues showed NE enrichment for several proteins mutated in muscular dystrophies and cardiomyopathies, including multiple members of the dystrophin-glycoprotein complex (see muscle samples in Supplementary Data). While members of this complex were not previously reported to be associated with lamin A/C, fluorescent protein fusion and antibody staining in cell culture 15 suggest that this complex is enriched at close proximity to the NE, presumably in the perinuclear ER ( Fig. 2f and Supplementary Fig. 3c ). Similar findings are seen in some muscle and nonmuscle sarcoglycan (SGCA)-stained sections in the protein atlas project 16 . In support of our hypothesis, lamin A/C was also moderately enriched in primary skeletal muscle when BAR was applied with an antibody against SGCA (Supplementary Data).
differential proteomics
Qualitative and quantitative changes may be observed when comparing the protein interactome under different conditions, such as the presence or absence of a genetic variation, application of a treatment protocol, or variation of a tissue type. Identifying such changes is important for understanding the function of the target protein in that context. While a protein of interest may be in close proximity to multiple other proteins, only a small fraction of those proteins may be relevant to a specific function or process, and this fraction is more likely to change in that context.
As a proof of concept for differential proteomics, we compared the NE composition of naive HeLa cells with cells subjected to a 2-h 43 °C heat shock. As expected, in control (naive) cells, the heavyto-light ratio was very close to 1, particularly when multiple peptides were used to calculate the ratio (Supplementary Fig. 4a,b and Supplementary Data). By contrast, when comparing a control with a heat-shocked sample, multiple proteins displayed deviant heavy-to-light ratios (Fig. 3a, blue bars) . These changes were mirrored in a reciprocal experiment (Fig. 3a, red bars) . Proteins identified include expected targets, such as multiple members of the family of heat-shock proteins. As these proteins become abundant during heat-shock conditions, the NE-bound fraction is also expected to increase. By contrast, we also identified elevated levels of non-heat-shock proteins. For example, Ku70 and Ku80 (also known as XRCC6 and XRCC5, respectively) are regulators of DNA-PK catalytic subunit (DNA-PKcs, also known as PRKDC) and members of the nonhomologous end-joining pathway. We found Ku70 and Ku80 to be ~2.5-fold more abundant near the NE following heat shock (Fig. 3a and Supplementary Data) . In contrast, no enrichment was seen for DNA-PKcs.
We validated the conclusion that Ku70 and Ku80 localize near lamin A/C using Förster resonance energy transfer (FRET) (Supplementary Fig. 5 ) and also observed an increase in Ku70 and Ku80 nuclear peripheral localization using immunofluorescence following heat shock ( Fig. 3b and Supplementary Fig. 6a ). Ku70 was previously identified 1,2 as a lamin A/C-binding protein, and heat shock inactivates Ku80 and drives its aggregation 17 . HSPA8, known to bind Ku70 and suppress its nuclear import, also showed a similar NE increase (Fig. 3a, Supplementary Fig. 6a and Supplementary Data). These changes reflect changes in molecular localization and not total protein abundance ( Supplementary  Fig. 6b and Beck et al. 17 ).
Progerin proximity labeling in transfected hela cells
Roughly 90% of cases of the premature aging disease Hutchinson Gilford progeria syndrome (HGPS) are caused by a de novo synonymous mutation of the lamin A/C gene 18 . This mutation activates a cryptic splice site, which results in a protein lacking 50 amino acids near the C terminus termed progerin. We applied BAR to HeLa cells transfected with GFP-LMNA or GFP-progerin and used a GFP antibody to direct biotin labeling. By observing the cells 24 h after transfection ( Fig. 3c and Supplementary Data), we were able to detect changes to the composition of the NE resulting directly from the acute expression of progerin. As expected, the heavy-to-light ratio for most lamin A/C peptides was close to 1. Only three peptides exhibited a significant deviation from this ratio, all of which overlapped with the exon-11-encoded 50-amino-acid stretch found only in lamin A/C and not in progerin, thus demonstrating our ability to distinguish between isoforms even in a wild-type lamin A/C endogenous background (Fig. 3d) (Fig. 3e) , which was previously reported to bind progerin 19 .
nuclear envelope proximity labeling in primary hGPs fibroblasts To detect changes in NE composition resulting from progerin expression in primary tissue culture, we compared the NE composition of control fibroblasts with fibroblasts donated by a patient with HGPS (Fig. 3f and Supplementary Data) . We detected changes in the abundance of several known NE proteins, including decrease of lamin B2 and RANBP2 and an increase in nesprin-1 and SUN2 ( Fig. 3g and Supplementary Data) . Additionally, in HGPS fibroblasts, we saw a NE decrease in polymerase I and transcript release factor (PTRF, also known as CAVIN1) and its interactor caveolin-1 (CAV1). Mutations in proteins of the PTRF and Caveolin families are associated with lipodystrophy and muscular dystrophy 20 .
Only a small fraction of CAV1 localizes near the nuclear membrane and may be available for NE interactions ( Supplementary  Fig. 7a ). As CAV1 was highly enriched in our muscle NE data sets, we looked at this more biologically relevant tissue. Indeed, a significant fraction of CAV1 is found at the nuclear membrane ( Fig. 3h and Supplementary Fig. 7b ) in muscle tissues.
discussion
We have developed a generalizable method for the identification of proteins in close proximity to an antigen of interest, validated the sensitivity and specificity of the method by applying it to mitochondria, and successfully applied it to characterize the NE composition in multiple cell lines and tissues.
Advantages and limitations of the proximity-based labeling method
By replacing enzyme fusion with antibodies, our method offers several advantages. BAR does not need a separate cell line or animal model to be generated for every protein of interest. Our use of antibodies prevents any artifacts related to protein fusion. Nonetheless, our method has several drawbacks. These include the requirement for a monospecific antibody that works well in tissue sections and is not sensitive to fixation artifacts. The labeling resolution does not distinguish direct interactions from proximal proteins. We use label-free quantification in our current method, which does not allow the detection of small changes via differential proteomics. In the future the use of isobaric mass tags (such as TMT labels) can be used for this purpose (see Supplementary Protocol).
tissue specificity Previous studies 1,2,4-6 characterizing the lamin interactome analyzed single cell lines. To gain insight into how specific mutations in lamin A/C cause multiple distinct clinical conditions, we analyzed the lamin interactome of multiple cell lines and primary human tissues. Certain proteins known to be clinically relevant, which were not identified by previous studies nor by BAR as lamin A/C interactors in HeLa cells, were identified by BAR in disease-relevant primary tissues. For example, primary muscle tissue shows NE enrichment for members of the dystrophin-glycoprotein complex. Mutations in this complex can result in various muscle dystrophies that resemble the muscle dystrophies caused by lamin A/C mutations. We show that multiple members of the dystrophin-glycoprotein complex are found in close proximity to the NE in skeletal muscle (Fig. 2f, Supplementary Fig. 3c and Supplementary Data). Interestingly, mutations to the dystrophin protein can cause NE abnormalities that progress with cell passage 21 . The dystrophin-glycoprotein complex has a structural role in linking the cytoskeleton to the extracellular matrix. In view of its enrichment at the nuclear periphery (Fig. 2f, ref. 15 ) and the nuclear deformations caused by DMD mutations 21 , we speculate that this complex may have a structural role in regulating NE morphology and nuclear position in muscle tissue. As multiple members of the dystrophin-glycoprotein complex are transmembrane proteins, it is even possible that the complex penetrates into the perinuclear space, where it may facilitate interactions with proteins of the inner nuclear membrane. In support of this hypothesis, mutations to dystrophin or δ-sarcoglycan alter the distribution of NE proteins lamin A/C, emerin and nesprin-2 (refs. 21, 22) .
differential proteomics
Comparing the interactome of a target protein under various conditions can help identify interactions that are important for a specific function. In HeLa cells expressing progerin or in HGPS fibroblasts, we were able to replicate many known changes to the NE composition, as well as to identify novel disease-relevant proteins. These include RanBP2 and linker of nucleoskeleton and cytoskeleton (LINC) complex members nesprin-1 and SUN2, all of which have important roles in laminopathies [23] [24] [25] [26] [27] , as well as PTRF, which was not previously known to associated with progerin. Interestingly, lamin A is known to regulate PTRF transcription 28 , and PTRF and CAV1 inhibit NRF2, promoting stress-induced premature senescence 29 . We note that while PTRF and CAV1 peptides are hardly seen in HeLa cells, these proteins gave a robust signal in fibroblasts, as well as in primary muscle tissue. Moreover, clear nuclear membrane localization of CAV1 was seen only in muscle samples (Fig. 3h) , emphasizing the need to explore changes to the NE composition in a relevant tissue. In future studies, this method can be leveraged to characterize the interactome of various proteins directly from clinical samples of patients and controls, thus accounting for the effect of both genetic and nongenetic factors, like a patient′s life history, on the interactome. BAR represents a general approach for identifying interactors of modified proteins or other biomolecules simply by using the appropriate antibody to target the molecule of interest. methods Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
online methods A list of antibodies (including clone names and providers), plasmids, and cell lines used is presented in Supplementary Table 1  (refs. 32-34 ).
Cell culture. Cells were grown without antibiotics as described below. All cell lines were tested for mycoplasma (MycoFluor Mycoplasma detection kit, Invitrogen). Fibroblasts cell identity was further validated by analyzing deep-sequencing data generated for other projects.
Human tissue samples. Cadaveric adipose and muscle tissues used in this study were obtained from the National Disease Research Interchange (NDRI) biorepository, exempted by the NIH Office of Human Subjects Research.
Mouse tissue preparation.
All animal experiments were approved by NHGRI animal care and use committee. Experiments were performed according to institutional guidelines in accordance with The Guide for the Care and Use of Laboratory Animals and the AVMA guidelines for the Euthanasia of Animals.
C57BL/6 mice were housed in an AAALAC Accredited SPF Animal facility.
Perfusion was performed on 4 month old males by achieving a surgical plane of anesthesia characterized by loss of consciousness, loss of reflex muscle response and loss of response to noxious stimuli in accordance with the AVMA guidelines for the Euthanasia of Animals using Tribromoethanol (Avertin 1.25%, 0.04 ml/g BW IP). For mass-spectrometry experiments, perfusion of PBS (pH 7.2) followed by 2% paraformaldehyde in PBS was used for continuous fixation for 60 min. Extracted tissues were flash frozen in liquid nitrogen.
Heat shock. T75 flasks of SILAC-labeled HeLa cells were transferred to an incubator preheated to 43 °C for 2 h and immediately processed. 35 and as a Supplementary Protocol. Briefly, cell or tissue samples were fixed in 4% formaldehyde (Thermo Fisher Scientific) for 10-30 min at room temperature (RT) and washed with PBST (PBS with 0.1% tween 20). Samples were incubated with 0.5% hydrogen peroxide for 10 min to deactivate any endogenous peroxidase activity. Samples were then permeabilized in PBS with 0.5% triton X-100 for 7 min and blocked for 2 h in 1% bovine serum albumin (BSA) in PBST. Samples were incubated with primary antibody overnight, washed with PBST, and incubated with an appropriate secondary antibody conjugated to horseradish peroxidase (HRP) for 3 h. After extensive washes, samples were incubated with biotin-tyramide (Perkin Elmer) for 10 min, and a dilution buffer containing hydrogen peroxide was added to a total volume of 150 µl. The reaction was stopped after 1-7 min (see Supplementary Data) by adding 850 µl of 500 mM sodium ascorbate (Sigma-Aldrich). After two washes with PBST, sample subsets were incubated with FITCavidin and analyzed under a microscope to validate the expected staining pattern of a given antibody. The remainder of the samples were heated to 99 °C for 1 h with 1.5% SDS and 1% sodium deoxycholate. Sample volume was adjusted to 1 ml with PBST, and biotinylated proteins were extracted with streptavidin beads (Thermo Fisher Scientific) according to the manufacturer′s protocol. For some samples, the presence of a specific protein bound to the beads was validated by western blot using ~10% of the beads. Samples were prepared for LC-MS/MS by incubation for 30 min at 37 °C in 10 mM DTT (Thermo Fisher Scientific) followed by 20 min in 50 mM Iodoacetamide (Thermo Fisher Scientific) at room temperature protected from light. Finally, samples were digested overnight in 37 °C with 2 µg trypsin (Promega) followed by a second 2 h digestion. ( 13 C 6 15 N 4 ; 84 mg/l) (Cambridge Isotope Laboratories) or their light equivalents (Sigma-Aldrich). Cells were passaged with nonenzymatic Gibco Cell Dissociation Buffer (Thermo Fisher Scientific). >95% heavy amino acid incorporation rate was validated by mass spectrometry.
Biotinylation by antibody recognition. A detailed protocol is available at the Protocol Exchange
Liquid chromatography-tandem mass spectrometry analysis.
Protein identification by LC-MS/MS analysis of peptides was performed using an Eksigent nanoLC-Ultra 1D plus system (Dublin, California) coupled to an LTQ Orbitrap Elite or Fusion Lumos mass spectrometer (Thermo Fisher Scientific, San Jose, California) using CID fragmentation. Peptides were first loaded onto a Zorbax 300SB-C18 trap column (Agilent, Palo Alto, California) at a flow rate of 6 µl/min for 6 min and then separated on a reversed-phase PicoFrit analytical column (New Objective, Woburn, Massachusetts) using a 120-min linear gradient of 5-35% acetonitrile in 0.1% formic acid at a flow rate of 250 nl/min. LTQ-Orbitrap Elite settings were as follows: spray voltage 1.5 kV; full MS mass range m/z 300 to 2,000. The LTQ-Orbitrap Elite was operated in a data-dependent mode; i.e., one MS1 high-resolution (60,000) scan for precursor ions is followed by six data-dependent nAture methods MS2 scans for precursor ions above a threshold ion count of 500 with collision energy of 35%.
Database search criteria. Raw files generated by the LTQ Orbitrap Elite or Orbitrap Fusion Lumos were analyzed using Proteome Discoverer v1.4 software (Thermo Fisher Scientific) using Mascot (Matrix Science, London; version 2.5.1) or SEQUEST search engines. The search criteria were set to: database, Swiss Prot (Swiss Institute of Bioinformatics); taxonomy, human or mouse; enzyme, trypsin; miscleavages, two; variable modifications, oxidation (M), deamidation (NQ), isotope labeling of lysine (K + 8.014 Da) and arginine (R + 10.008 Da); fixed modifications, carbamidomethyl (C); MS peptide tolerance 20 p.p.m.; MS/MS tolerance as 0.8 Da.
For the in-gel-digestion data set, identifications were accepted based on one or more unique peptides with a false discovery rate (FDR) of 99% or higher. All other data sets were accepted based on two or more unique peptides with a false discovery rate (FDR) of 99% or higher.
Statistics and data analysis. Data sets were imported into a MySQL database. Comparisons involving external data sets were done by converting gene names into the HGNC (http://www. genenames.org/) standard or Uniprot accession (mitochondria data only). Full details on repeats are available as part of the Supplementary Data. Only biological repeats (i.e., complete processing of a new sample but potentially from the same cell line or tissue block) were included in the Supplementary Data. GFP-progerin and heat-shock experiments, as well as the human skeletal muscle tissue, were repeated once. A partial repeat of the human adipose sample, without unbound and no-antibody controls, was also performed. Three experiments of HGPS versus control fibroblasts were performed. P values for single proteins were calculated using one-sided t-test on peptide SILAC ratios. Investigators were not blinded to group allocations. Additional information can be found online at the Life Science Reporting Summary. Enrichment analysis. For non-SILAC samples, the enrichment factor (E) is set to be min(E No Ab , E Unbound ), where E No Ab is the area ratio of the bound to no-antibody control (nonspecific binding to beads), and E Unbound is the area ratio of the bound to unbound fractions, normalized to the total area ratios. For proteins found only in the bound sample, E was arbitrarily set to 1,000. If the area could be calculated for the bound but not the control sample, E was arbitrarily set to 100. Surprisingly, E was often lower for the target protein than for other known interactors. We speculate this is because of multiple biotinylations that decrease peptide identification by mass spectrometry. Known contaminants are shown in the raw data but removed from final lists and analysis.
In SILAC samples comparing different mutations or cell lines, protein quantities were normalized, setting the heavy/light average or lamin A/C ratio to 1.
Life Sciences Reporting Summary. Further information regarding the experimental design may be found in the Life Sciences Reporting Summary.
Data availability. The data that support the findings of this study are available from the corresponding author upon request. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 36 partner repository with the data set identifier PXD004736. Source data files for Figures 1-3 
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